Home > Boards > US OTC > Medical - Healthcare >

Decision Diagnostics Corp. (DECN)

DECN RSS Feed
Add DECN Price Alert      Hide Sticky   Hide Intro
Moderator: nonsequetor, plutoniumimplosion
Search This Board: 
Last Post: 5/25/2019 4:34:40 PM - Followers: 224 - Board type: Free - Posts Today: 0

http://www.decisiondiagnostics.co/

http://www.pharmatechsolutions.co/products.html


 

About Us: Decision Diagnostics Corp.

Decision Diagnostics is a small and friendly company that specializes in prescription and non-prescription diagnostics and home testing products. Through our subsidiary, PharmaTech Solutions, Inc., we provide blood glucose home testing device including Genstrip50 and GenUltimate! test strips, as well as three exciting new concepts for blood testing monitors. These FDA cleared products are an affordable alternative for patients and healthcare providers. Decision Diagnostics also provides smart phone based electronic medical record (EMR) applications to be used by physicians at the point of care. These mobile applications allow physicians to easily and efficiently access and update their patients’ histories, medication data, and care guidelines.

Decision Diagnostics Corp. is developing products that offer unique solutions in medical care and management by providing physicians with essential information at the point of care. Unlike other medical information systems using standard computer terminals, Decision Diagnostics Corp. uses smart phones, which allow physicians to carry, access and update their patients' histories, medication data, and best care guidelines - all at the point of care. Decision Diagnostics Corp. is a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies.

Decision Diagnostics Corp. has established a core management team experienced in all phases of health care, data management and the Web. Together, the development and management teams are creating the most advanced medical devices around.

Read Recent Press Releases »

Review Recent Financial Reports »

Visit PharmaTech Solutions, Inc. »

Board of Directors

Keith Berman

Chief Financial Officer, Secretary and Director

Specializing in healthcare software including intranet and Internet systems for the past 27 years and a founder of instaCare Corp., Keith Berman brings more than 35 years experience in the healthcare field, having worked with such companies as Technicon Corporation and Boehringer-Mannheim Corporation. He is the founder of Medicius Inc., and served as that company’s president at the time of its acquisition by instaCare. Mr. Berman also was the founder of Cymedix, the operating division of Ramp Corp. (formerly Medix Resources) (AMEX: RCO), a public company. Mr. Berman received his B.A. and M.B.A. from Indiana University.

Robert Jagunich

Director

Robert Jagunich brings 40 years of experience in the medical systems and device industry. Since joining Decision Diagnostics Corp., Mr. Jagunich has also served president at New Abilities Systems, a privately held manufacturer of advanced electronic systems used in rehabilitation. From April 1996 through December 1997, he served as a director of Cymedix Corporation, the operating division of Ramp Corp. (AMEX: RCO). Mr. Jagunich also has provided consulting services to such clients as Johnson and Johnson and has served as a senior executive in such publicly held companies as Laserscope and Acuson. He received his B.S., M.S. and M.B.A. from the University of Michigan.

 

DECN Security Details

Share Structure

Market Cap
7,432,493
03/29/2019
Authorized Shares
494,995,000
03/01/2019
Outstanding Shares
140,156,392
03/01/2019
Restricted
5,891,505
03/01/2019
Unrestricted
134,264,887
03/01/2019
Held at DTC
Not Available
Float
104,569,393
06/09/2018
Par Value
0.00



OTC Disclosure & News Service

 

https://www.accesswire.com/544741/DECN-Sets-Plan-to-Make-Upcoming-Patent-Infringement-Appeal-Hearing-and-Mediation-with-Johnson-Johnson-a-Foundation-for-Substantial-Recovery
https://www.accesswire.com/544380/DECNs-Appeal-Nearing-Oral-Arguments-in-its-Patent-Battle-with-Johnson-Johnson-Over-the-Unjust-Ruling-in-the-Nevada-Lower-Court
https://www.accesswire.com/542607/In-Prelude-to-Probable-Transaction-DECN-Decides-to-Infuse-its-Outre-Precise-TBG-Technology-to-its-GenChoice-Test-Strip-Now-in-FDA-510k-Review
DECN Launches Its Genultimate 4Pets and Avantage Meter, Ground-Breaking Products for the Testing of Dogs, Cats and Horses, Receives First Retail Orders, Establishes Innovative Rebate ProgramPress Release | 03/14/2019
DECN in Pact with Alpha Capital AnstaltPress Release | 03/14/2019
       
       
 
Filings and Disclosure
OTC Disclosure & News
Active
Inactive
All
Publish Date
Title
Period End Date
Status
05/15/2019 Quarterly Report - OTC PICK 1Q2019 QUARTERLY REPORT FINANCIALS_FOOTNOTES_SCHEDULES 03/31/2019 A
05/15/2019 Management Discussion and Analysis - OTC PINK 1Q2019 QUARTERLY REPORT MANAGEMENTS' DISCUSSION & ANALYSIS 03/31/2019 A
05/15/2019 Supplemental Information - OTC PINK 1Q2019 QUARTERLY REPORT SUPPLEMENTAL INFORMATION 03/31/2019 A
04/23/2019 Attorney Letter with Respect to Current Information - ATTORNEY COOK LETTER REVISED TO CORRECT AN ERROR 12/31/2018 A
04/01/2019 Supplemental Information - OTC PINK 2018 ANNUAL REPORT SUPPLEMENTAL INFORMATION 12/31/2018 A
04/01/2019 Management Discussion and Analysis - OTC PINK 2018 ANNUAL REPORT MANAGEMENT'S DISCUSSION & ANALYSIS 12/31/2018 A
04/01/2019 Annual Report - OTC PINK 2018 ANNUAL REPORT BALANCE SHEET FINANCIALS SCHEDULES AND FOOTNOTES 12/31/2018 A
11/14/2018 Supplemental Information - OTC PINK 3Q 2018 SUPPLEMENTAL INFORMATION 09/30/2018 A
11/14/2018 Management Discussion and Analysis - OTC PINK 3Q 2018 MANAGEMENT DISCUSSION & ANALYSIS 09/30/2018 A
11/14/2018 Quarterly Report - OTC PINK 2Q 2018 FINANCIALS_FOOTNOTES & STATEMENTS OF CASH FLOWS AND EQUITY 09/30/2018 A
08/14/2018 Supplemental Information - OTC PINK 2Q 2018 SUPPLEMENTAL INFORMATION & DISCLOSURES 06/30/2018 A
08/14/2018 Management Discussion and Analysis - OTC PINK 2Q 2018 MANAGEMENT DISCUSSION & ANALYSIS 06/30/2018 A
08/14/2018 Quarterly Report - OTC PINK 2Q 2018 FINANCIALS_FOOTNOTES & STATEMENTS OF CASH FLOWS AND EQUITY 06/30/2018 A
05/17/2018 Quarterly Report - REVISED 1Q 2018 FINANCIALS_FOOTNOTES AND SCHEDULES 03/31/2018 A
05/15/2018 Supplemental Information - OTC PINK 1Q 2018 SUPPLEMENTAL INFORMATION & DISCLOSURES 03/31/2018 A
05/15/2018 Management Discussion and Analysis - OTC PINK 1Q 2018 MANAGEMENT'S DISCUSSION & ANALYSIS 03/31/2018 A
03/31/2018 Attorney Letter with Respect to Current Information - OTC PINK ANNUAL REPORT 2017 -- ATTORNEY LETTER WITH RESPECT TO CURRENT INFORMATION 12/31/2017 A
03/31/2018 Supplemental Information - OTC PINK 2017 ANNUAL REPORT SUPPLEMENTAL INFORMATION & DISCLOSURES 12/31/2017 A
03/31/2018 Management Discussion and Analysis - OTC PINK 2017 ANNUAL REPORT MANAGEMENTS' DISCUSSION & ANALYSIS 12/31/2017 A
03/31/2018 Annual Report - OTC PINK 2017 ANNUAL REPORT FINANCIALS_FOOTNOTES_SCHEDULES OF EQUITY_&_CASH FLOWS 12/31/2017 A
11/17/2017 Quarterly Report - OTC PINK 3Q 2017 BALANCE SHEET_FOOTNOTES_STATEMENTS OF CASH FLOWS & EQUITY REVISED 09/30/2017 A
11/14/2017 Supplemental Information - OTC PINK QUARTERLY REPORT 3Q 2017 09/30/2017 A
11/14/2017 Management Discussion and Analysis - OTC PINK QUARTERLY REPORT FOR 3Q 2017 09/30/2017 A
08/15/2017 Supplemental Information - OTC PINK QUARTERLY REPORT FOR 2Q 2017 SUPPLEMENTAL INFORMATION 06/30/2017 A
08/15/2017 Management Discussion and Analysis - OTC PINK QUARTERLY REPORT 2Q 2017 MANAGEMENTS' DISCUSSION & ANALYSIS (amended) 06/30/2017 A
08/14/2017 Quarterly Report - OTC PINK QUARTERLY REPORT FOR 2Q 2017 BALANCE SHEET_FOOTNOTES & STATEMENTS OF CASH FLOWS & EQUITY 06/30/2017 A
07/20/2017 Officer/Director Disclosure - William Lyons Resigns DECN Board of Directors 06/30/2017 A
06/22/2017 Officer/Director Disclosure - ROBERT JAGUNICH RE=ELECTED TO DECN BOARD OF DIRECTORS AFTER SHORT RETIREMENT 03/31/2017 A
05/31/2017 Officer/Director Disclosure - DECN CHAIRMAN ROBERT JAGUNICH RETIRES FROM BOARD OF DIRECTORS 03/31/2017 A
05/26/2017 Quarterly Report - OTC PINK QUARTERLY REPORT 1Q2017 BALANCE SHEET_FOOTNOTES & STATEMENTS OF EQUITY AND CASH FLOWS 03/31/2017 A
05/15/2017 Management Discussion and Analysis - OTC PINK QUARTERLY REPORT 1Q2017 MANAGEMENTS DISCUSSION AND ANALYSIS 03/31/2017 A
05/15/2017 Supplemental Information - OTC PINK QUARTERLY REPORT 1Q2017 SUPPLEMENTAL DISCLOSURE INFORMATION 03/31/2017 A
03/31/2017 Management Discussion and Analysis - OTC PINK ANNUAL REPORT 2016_MANAGEMENTS' DISCUSSION & ANALYSIS 12/31/2016 A
03/31/2017 Annual Report - OTC PINK 2016 ANNUAL REPORT__BALANCE SHEET FOOTNOTES & SCHEDULES 12/31/2016 A
03/30/2017 Supplemental Information - OTC MARKETS 2016 ANNUAL REPORT_SUPPLEMENTAL DISCLOSURE INFORMATION 12/31/2016 A
03/30/2017 Attorney Letter with Respect to Current Information - OPINION LETTER FROM ATTORNEY THOMAS COOK: CURRENT INFORMATION 12/31/2016 A
11/15/2016 Supplemental Information - OTC PINK CURRENT 3Q 2016 SUPPLEMENTAL DISCLOSURE INFORMATION 09/30/2016 A
11/15/2016 Management Discussion and Analysis - OTC PINK CURRENT 3Q 2016 MANAGEMENTS' DISCUSSION & ANALYSIS 09/30/2016 A
11/15/2016 Quarterly Report - OTC PINK CURRENT 3Q 2016 BALANCE SHEET_P&L & STATEMENTS OF EQUITY & CASH FLOWS 09/30/2016 A
09/08/2016 Quarterly Report - OTC PINK 2Q 2016 BALANCE SHEET & FOOTNOTES & STATEMENTS OF EQUITY & CASH FLOWS 06/30/2016 A
09/08/2016 Management Discussion and Analysis - OTC PINK 2q 2016 MANAGEMENTS' DISCUSSION AND ANALYSIS 06/30/2016 A
08/15/2016 Supplemental Information - OTC PINK 2Q 2016 SUPPLEMENTAL DISCLOSURE INFORMATION 06/30/2016 A
05/16/2016 Supplemental Information - 1Q 2016 OTC MARKETS SUPPLEMENTAL DISCLOSURE INFORMATION 03/31/2016 A
05/16/2016 Management Discussion and Analysis - 1Q 2016 OTC MARKETS MANAGEMENTS' DISCUSSION & ANALYSIS 03/31/2016 A
05/16/2016 Quarterly Report - 1Q 2016 OTC MARKETS BALANCE SHEET_FOOTNOTES_STATEMENTS OF CASH FLOWS & EQUITY 03/31/2016 A
04/03/2016 Management Discussion and Analysis - OTC PINK 2015 ANNUAL REPORT, MANAGEMENTS' DISCUSSION AND ANALYSIS (revised to correct errors) 12/31/2015 A
04/03/2016 Annual Report - OTC PINK 2015 ANNUAL REPORT BALANCE SHEET, STATEMENTS OF EQUITY AND CASH FLOWS AND FOOTNOTES (revisions to correct errors) 12/31/2015 A
03/31/2016 Attorney Letter with Respect to Current Information - ATTORNEY LETTER WITH RESPECT TO CURRENT INFORMATION -- 2015 DECN 12/31/2015 A
03/30/2016 Supplemental Information - ANNUAL REPORT 2015: ISSUER SUPPLEMENTAL INFORMATION 12/31/2015 A
11/18/2015 Supplemental Information - Supplemental Information -- OTC MARKETS 3Q 2015 SUPPLEMENTAL INFORMATION (correction of errors) 09/30/2015 A
 
DECN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DECN News: DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV... 05/09/2019 09:55:00 AM
DECN News: DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY 04/04/2019 10:00:00 AM
DECN News: Withdrawal of Offering Statement Under Regulation a (1-a-w) 03/18/2019 04:35:21 PM
DECN News: Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) 02/25/2019 03:34:02 PM
DECN News: DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE 01/30/2019 10:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#55583  Sticky Note DECN to Discuss in Detail Three Major nonsequetor 05/23/19 09:35:43 AM
#53363  Sticky Note DECN Engages Second Korean Manufacturing Partner to Raise plutoniumimplosion 12/17/18 10:04:15 AM
#55605   Tell him to sue the FDA then (he'll lose!) plutoniumimplosion 05/25/19 04:34:40 PM
#55604   It could very well be problematic! IPwatcher 05/25/19 04:20:18 PM
#55603   It could very well be problematic! IPwatcher 05/25/19 04:19:23 PM
#55602   "AI" stands for Additional Information. It doesn't stand IPwatcher 05/25/19 04:00:50 PM
#55598   Leading the sheep to slaughter zalicuslicious 05/24/19 04:26:14 PM
#55597   It could very well be problematic! zalicuslicious 05/24/19 03:11:03 PM
#55596   "FDA have issued a deficiency notice in regard plutoniumimplosion 05/24/19 01:22:12 PM
#55595   What is the point? IPwatcher 05/24/19 12:25:06 PM
#55594   My 10 year old granddaughter can write a plutoniumimplosion 05/24/19 09:17:27 AM
#55591   My 10 year old granddaughter can write a mugsy4900 05/24/19 06:41:47 AM
#55590   What a dumb Bozo Berman announcement. What is plutoniumimplosion 05/23/19 07:25:00 PM
#55589   What a dumb Bozo Berman announcement. What is Johnny_C 05/23/19 05:41:25 PM
#55587   Nobody believes anything BOZO BERMAN writes any more. plutoniumimplosion 05/23/19 02:27:46 PM
#55586  Restored "We see bright light up ahead ...." .......that Hopefull17 05/23/19 02:24:26 PM
#55585   This latest PR is an example of things Hopefull17 05/23/19 02:19:54 PM
#55584   Bring on the fluffernutter PR. Nobody believes anything zalicuslicious 05/23/19 10:49:47 AM
#55583   DECN to Discuss in Detail Three Major nonsequetor 05/23/19 09:35:43 AM
#55582   50k SELL at .238.....OUCH. Take the money and run. zalicuslicious 05/22/19 09:41:03 AM
#55581   Perhaps YOU can give us all a little zalicuslicious 05/22/19 08:28:16 AM
#55579   Perhaps you can give us all a little plutoniumimplosion 05/21/19 04:21:08 PM
#55578   Sales and profit are the same for a Hopefull17 05/21/19 03:51:37 PM
#55577   A real CEO is expected to execute and plutoniumimplosion 05/21/19 02:56:06 PM
#55576   LifeScan Enters into Agreement with Sanvita Medical to Bakerco 05/21/19 02:33:45 PM
#55575   SLOW AND STEADY....BLEED zalicuslicious 05/21/19 01:04:36 PM
#55574   Still waiting for a name of a company Johnny_C 05/21/19 12:08:43 PM
#55573   Someone should take over this company,BOZO SURE AS mugsy4900 05/21/19 11:43:31 AM
#55571   KB seems to be "waiting" on a lot Hopefull17 05/21/19 10:18:08 AM
#55569   CEO MF Berman failed and continues to do plutoniumimplosion 05/20/19 08:53:54 PM
#55568   Three years since DECN claimed it shed all Hopefull17 05/20/19 07:22:43 PM
#55567   Name a Company that Bozo Berman has been plutoniumimplosion 05/20/19 03:45:47 PM
#55565   Why don't you loan your friend Bozo Berman Johnny_C 05/20/19 10:44:17 AM
#55564   You can buy in the open market....all you plutoniumimplosion 05/20/19 10:11:02 AM
#55563   But one is a CEO and the other zalicuslicious 05/20/19 10:11:00 AM
#55562   40% spread...there's some good investing strategy...LOL! zalicuslicious 05/20/19 10:09:12 AM
#55561   Name a Company that Bozo Berman has been plutoniumimplosion 05/20/19 09:57:20 AM
#55560   OMG....shut the lights on your way out.....TK zalicuslicious 05/20/19 09:53:26 AM
#55559   You can buy in the open market....all you zalicuslicious 05/20/19 09:35:55 AM
#55558   Mugsy, Bozo Berman will be happy to know that Johnny_C 05/20/19 09:35:53 AM
#55557   Very strong possibility that Bozo Berman will have Johnny_C 05/20/19 08:19:07 AM
#55556   what a piece of trash this company and Johnny_C 05/20/19 07:22:06 AM
#55555   what a piece of trash this company and plutoniumimplosion 05/18/19 08:03:47 PM
#55554   Decn will probably be a .02 cent stock mugsy4900 05/18/19 03:32:42 PM
#55553   Looking at many filings, PR, Sales Revenue (or Hopefull17 05/18/19 02:43:09 PM
#55552   As far as your question, as I have plutoniumimplosion 05/18/19 02:35:49 PM
#55551   That cannot happen until a message board poster Hopefull17 05/18/19 02:34:12 PM
#55549   DECN TALK is useless ….. show some execution! plutoniumimplosion 05/18/19 01:14:32 PM
#55548   Buying DECN here is just.... SLIGHTLY STOOPID plutoniumimplosion 05/18/19 01:12:36 PM
#55547   I thought DECN already had an in-store supplier Hopefull17 05/18/19 12:28:48 PM
#55546   Like I stated. Bozo Berman is an expert Johnny_C 05/17/19 06:55:59 PM
#55545   WOW RED everywhere on this chart! zalicuslicious 05/17/19 03:23:31 PM
PostSubject